Aclaris Therapeutics
ACRS
ACRS
104 hedge funds and large institutions have $737M invested in Aclaris Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 54 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 104 → 104 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
104
Holding in Top 10
3
Calls
$4.24M
Puts
$354K
Top Buyers
| 1 | +$31M | |
| 2 | +$13.2M | |
| 3 | +$9.59M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$6.79M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.68M |
Top Sellers
| 1 | -$8.04M | |
| 2 | -$4.39M | |
| 3 | -$4.06M | |
| 4 |
PC
PointState Capital
New York
|
-$3.93M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.24M |